Cargando…

Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study

BACKGROUND: Breast cancer patients’ quality of life (QoL) after surgery has been reported to improve significantly over time. Little is known about QoL recovery after sentinel lymph node biopsy (SLNB) in comparison to axillary lymph node dissection (ALND). METHODS: 175 of 195 stage I/II breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kootstra, Jan, Hoekstra-Weebers, Josette E. H. M., Rietman, Hans, de Vries, Jaap, Baas, Peter, Geertzen, Jan H. B., Hoekstra, Harald J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Breast Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518082/ https://www.ncbi.nlm.nih.gov/pubmed/18597146 http://dx.doi.org/10.1245/s10434-008-9996-9

Ejemplares similares

A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
por: Kootstra, Jan J., et al.
Publicado: (2010)

Quality of Life After Axillary or Groin Sentinel Lymph Node Biopsy, With or Without Completion Lymph Node Dissection, in Patients With Cutaneous Melanoma
por: de Vries, Mattijs, et al.
Publicado: (2009)

The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer
por: Li, Peiyong, et al.
Publicado: (2023)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
por: Qiu, Peng-Fei, et al.
Publicado: (2019)

Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature
por: Francissen, Claire M. T. P., et al.
Publicado: (2012)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019)

Discordance of Intraoperative Frozen Section Analysis with Definitive Histology of Sentinel Lymph Nodes in Breast Cancer Surgery: Complementary Axillary Lymph Node Dissection is Irrelevant for Subsequent Systemic Therapy
por: Geertsema, D., et al.
Publicado: (2010)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Same‐day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer
por: Tamminen, Anselm, et al.
Publicado: (2022)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
por: van Deurzen, Carolien H. M., et al.
Publicado: (2008)

Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019)

Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal
por: Cebrecos, Isaac, et al.
Publicado: (2023)

Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
por: Killelea, Brigid K., et al.
Publicado: (2018)

Intramammary Sentinel Lymph Nodes: What is the Clinical Significance?
por: Cox, Charles E., et al.
Publicado: (2008)

Imprint Cytology Predicts Axillary Node Status in Sentinel Lymph Node Biopsy
por: Bell, Zarina, et al.
Publicado: (2010)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Tattoo pigment mimicking axillary lymph node calcifications on mammography
por: Paul Litton, Tyler, et al.
Publicado: (2020)

Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic
por: Cocco, Daniela, et al.
Publicado: (2021)

Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
por: Peintinger, F, et al.
Publicado: (2003)

Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
por: Gebhardt, Brian J., et al.
Publicado: (2018)

Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence
por: Poodt, Ingrid G. M., et al.
Publicado: (2018)

The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study
por: Suami, Hiroo, et al.
Publicado: (2007)

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
por: Appelgren, Matilda, et al.
Publicado: (2022)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
por: TAKAMARU, TOMOKO, et al.
Publicado: (2014)

Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer
por: Gherghe, M, et al.
Publicado: (2015)

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
por: Si, Jing, et al.
Publicado: (2022)

ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes
por: Den Toom, Inne J., et al.
Publicado: (2016)

Sentinel node biopsy and radical lymph node dissection for advanced melanoma in the elderly
por: Desiato, V, et al.
Publicado: (2011)

Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer
por: van Roozendaal, Lori M., et al.
Publicado: (2015)

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)

Extracapsular Invasion of Sentinel Lymph Nodes Is Not Associated With Disease Recurrence in Breast Cancer
por: Fujii, Takaaki, et al.
Publicado: (2014)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4nnu46sl1invtp0pp63i22f1lc